Excellerate Bioscience is delighted to announce its relocation to a new, cutting-edge laboratory and office space located within NG2 Business Park in central Nottingham, UK. This move marks a new chapter for Excellerate, enabling the company to enhance its CRO operations delivering excellence in the field of in vitro pharmacology, cell biology and immunology.
The relocation to NG2 Business Park signifies another milestone for the company’s growth and development to accommodate an expanding team. The new site offers a larger and state-of-the-art working environment, providing the company with the facilities to advance its assay and screening platform development across our expanding project portfolio. The central location of the NG2 site in Nottingham ensures easy accessibility for clients, partners, and employees, facilitating seamless collaboration and fostering strong business relationships.
Nick Holliday, CSO, commented “This is a fantastic step in Excellerate’s journey as a leading pharmacology CRO, providing new facilities of the highest calibre to match the expertise and dedication of our staff, and giving us exciting options for further expansion of our business in 2024. We are looking forward to welcoming our clients, new and old, to NG2!”
Founded in 2016, Excellerate Bioscience boasts a leadership team with over 50 years of combined experience. Their expertise, coupled with an international reputation in cellular and biochemical pharmacology, has led the company to become a trusted CRO partner for international pharmaceutical companies, SMEs, and academic institutions in the preclinical drug discovery space. The company’s team of dedicated, collaborative scientists have contributed to the successful completion of numerous projects and partnerships within the pharmaceutical industry across a wide range of targets and disease areas.
To learn more about how Excellerate Bioscience can support your drug discovery program, please get in touch here.